Miragen Therapeutics, Inc. (MGEN) is a Medical Specialities company listed on NASDAQ. There were no new wire items for MGEN in the last 30 days. The most recent was published Mar 15, 2021.
Latest news
25 items- 13D/GSEC Form SC 13G/A filed by Miragen Therapeutics, Inc.SC 13G/A - Viridian Therapeutics, Inc.\DE (0001590750) (Subject)
- 13D/GSEC Form SC 13G filedSC 13G - Viridian Therapeutics, Inc.\DE (0001590750) (Subject)
- 13D/GSEC Form SC 13G filedSC 13G - Viridian Therapeutics, Inc.\DE (0001590750) (Subject)
- 13D/GSEC Form SC 13G/A filedSC 13G/A - Viridian Therapeutics, Inc.\DE (0001590750) (Subject)
- 13D/GSEC Form SC 13G/A filedSC 13G/A - Viridian Therapeutics, Inc.\DE (0001590750) (Subject)
- INSIDERSEC Form 4 filed by L Joseph Turner4 - Viridian Therapeutics, Inc.\DE (0001590750) (Issuer)
- INSIDERSEC Form 4 filed by Evan Peter Harwin4 - Viridian Therapeutics, Inc.\DE (0001590750) (Issuer)
- INSIDERSEC Form 4 filed by S. Jeffrey Hatfield4 - Viridian Therapeutics, Inc.\DE (0001590750) (Issuer)
- INSIDERSEC Form 4 filed by Tomas Kiselak4 - Viridian Therapeutics, Inc.\DE (0001590750) (Issuer)
- INSIDERSEC Form 4 filed by Arlene Morris4 - Viridian Therapeutics, Inc.\DE (0001590750) (Issuer)
- INSIDERSEC Form 3 filed by Barrett Katz3 - Viridian Therapeutics, Inc.\DE (0001590750) (Issuer)
- INSIDERSEC Form 4 filed by Barrett Katz4 - Viridian Therapeutics, Inc.\DE (0001590750) (Issuer)
- INSIDERSEC Form 4 filed by A. Jason Leverone4 - Viridian Therapeutics, Inc.\DE (0001590750) (Issuer)
- INSIDERSEC Form 4 filed by Jonathan Violin4 - Viridian Therapeutics, Inc.\DE (0001590750) (Issuer)
- SECSEC Form 8-K filed8-K - Viridian Therapeutics, Inc.\DE (0001590750) (Filer)
- INSIDERSEC Form 4 filed by Diana Escolar4 - Viridian Therapeutics, Inc.\DE (0001590750) (Issuer)
- INSIDERSEC Form 4 filed by M. Lee Rauch4 - Viridian Therapeutics, Inc.\DE (0001590750) (Issuer)
- SECSEC Form SC 13G filedSC 13G - Viridian Therapeutics, Inc.\DE (0001590750) (Subject)
- PRmiRagen Therapeutics Announces Company Name Change to Viridian Therapeutics and New Executive Appointments, Including Expansion of Leadership TeamJonathan Violin, Ph.D., M.B.A. appointed President, CEO and director Barrett Katz, M.D., M.B.A. joins Viridian as Chief Medical OfficerViridian is developing VRDN-001 and VRDN-002 for the treatment of thyroid eye diseaseCompany recently licensed exclusive rights from Xencor, Inc. to develop and commercialize therapeutic antibodies targeting IGF-1R incorporating Xtend™ Fc half-life extension technology BOULDER, Colo., Jan. 19, 2021 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a development-stage biotechnology company, today announced its name change to Viridian Therapeutics, Inc. (“Viridian”). Beginning tomorrow, Viridian will trade on NASDAQ under the ticker symbol "VR
- SECSEC Form 4 filed by Stuart William Marshall4 - MIRAGEN THERAPEUTICS, INC. (0001590750) (Issuer)
- SECSEC Form SC 13G filedSC 13G - MIRAGEN THERAPEUTICS, INC. (0001590750) (Subject)
- SECSEC Form SC 13G filedSC 13G - MIRAGEN THERAPEUTICS, INC. (0001590750) (Subject)
- SECSEC Form SC 13G filedSC 13G - MIRAGEN THERAPEUTICS, INC. (0001590750) (Subject)
- SECSEC Form SC 13D filedSC 13D - MIRAGEN THERAPEUTICS, INC. (0001590750) (Subject)
- SECSEC Form 8-K filed8-K - MIRAGEN THERAPEUTICS, INC. (0001590750) (Filer)
MGEN FAQ
6 questionsWhat is the latest news on MGEN?
Quantisnow has not tracked any new filings, ratings or press releases for MGEN in the last 30 days. The most recent wire item was published on March 15, 2021.Where does MGEN stock trade?
Miragen Therapeutics, Inc. (MGEN) is listed on NASDAQ.What sector and industry is MGEN in?
Miragen Therapeutics, Inc. operates in the Health Care sector, Medical Specialities industry.When did Miragen Therapeutics, Inc. go public?
Miragen Therapeutics, Inc. (MGEN) completed its IPO in 2014.What companies are similar to MGEN?
Notable peers in the same industry include UNH (UnitedHealth Group Incorporated), ANTM (Anthem Inc.), ELV (Elevance Health Inc.), CI (The Cigna Group), NTRA (Natera Inc.). Compare MGEN side-by-side with any of them on Quantisnow.How can I track MGEN on Quantisnow?
Quantisnow aggregates Miragen Therapeutics, Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MGEN to receive live email and push alerts on every new disclosure.